NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Bathurst and Talley's: The marriage goes sour
Markets Part 2

Bathurst and Talley's: The marriage goes sour

Talley’s joint venture with Bathurst started well, but something derailed it.

Pattrick Smellie 30 Jul 2025
SFO cut immigration fraud charges
Law & Regulation

SFO cut immigration fraud charges

Second SFO case collapses from unlawful evidence collection fear; impacts FMA, Du Val.

Garth Bray 29 Jul 2025
Accountant admits wrongdoing over Du Val
Property

Accountant admits wrongdoing over Du Val

Accountant dealt directly with Kenyon Clarke, and told Government business was solvent.

Maria Slade 28 Jul 2025